Welcome to our dedicated page for Milestone Scient SEC filings (Ticker: MLSS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Milestone Scientific Inc. filings document material events for a NYSE American-listed operating company with common stock trading under MLSS. Recent disclosures cover private placements of common stock and warrants, registration-rights and purchase agreements, use-of-proceeds language, and amendments to corporate governing documents that affect authorized share capital.
The company’s SEC records also describe shareholder voting results, director elections, auditor ratification and auditor changes, material agreements involving stockholder transfer restrictions, and liquidity-related audit disclosure, including going-concern language in the independent auditor’s report.
Milestone Scientific (MLSS) reported insider stock sales. On 10/20/2025, the filer sold 24,034 shares of common stock at $0.4527, leaving 9,131,192 shares beneficially owned directly. On 10/21/2025, the filer sold an additional 40,000 shares at $0.4398, with 9,091,192 shares directly owned afterward.
The form was filed by one reporting person. The signature block shows /S/ Dr. Pedro Palau, Liquidator.
Milestone Scientific (MLSS) disclosed insider stock sales on a Form 4. The reporting person sold common stock in three transactions: 10,158 shares on 10/10/2025 at $0.5501, 10,000 shares on 10/13/2025 at $0.55, and 30,000 shares on 10/14/2025 at $0.5395. Following these transactions, the reporting person beneficially owned 9,155,226 shares, held directly.
Milestone Scientific Inc. reported it received a NYSE American notice that it is not in compliance with continued listing standards under Sections 1003(a)(ii) and (iii). The company must submit a plan of compliance by November 7, 2025. If the plan is accepted, the listing can continue with periodic reviews.
The Exchange may initiate delisting procedures if the plan is not accepted, if progress is insufficient, or if the company fails to regain compliance by April 8, 2027. Management is pursuing options to address the deficiency and intends to submit a plan by the deadline.
Milestone Scientific Inc. reported it received a NYSE American notice that it is not in compliance with continued listing standards under Sections 1003(a)(ii) and (iii). The company must submit a plan of compliance by November 7, 2025. If the plan is accepted, the listing can continue with periodic reviews.
The Exchange may initiate delisting procedures if the plan is not accepted, if progress is insufficient, or if the company fails to regain compliance by April 8, 2027. Management is pursuing options to address the deficiency and intends to submit a plan by the deadline.
BP4 S.r.l., listed as a Director and 10% Owner, reported insider sales of common stock in MILESTONE SCIENTIFIC INC. (MLSS).
The filing shows two sales: 10,000 shares sold on 10/07/2025 at $0.45 and 30,000 shares sold on 10/08/2025 at $0.465, a total of 40,000 shares. Following the transactions, the reporting person reported beneficial ownership of 9,195,384 shares.
The form is signed by /s/ Dr. Pedro Palau, Liquidator on 10/09/2025. The transactions are reported as direct ownership changes and involve common stock only.
BP4 S.r.l., a director-level reporting person, reported the sale of a total of 19,210 shares of MILESTONE SCIENTIFIC INC. (MLSS) on 10/03/2025 at prices of $0.4491 and $0.45. After these disposals the reporting person beneficially owned 9,235,384 shares. No derivative transactions are reported and the Form 4 is signed by the liquidator on 10/08/2025.
BP4 S.r.l., listed as a director of Milestone Scientific Inc. (MLSS), reported a sale of 10,000 shares of the issuer's common stock on 09/11/2025 at a price of $0.594 per share. After the transaction the filing indicates beneficial ownership of 9,256,972 shares, held indirectly. The Form 4 was signed by Dr. Pedro Palau, Liquidator and filed on 09/15/2025. The filing shows a single non-derivative disposition and does not disclose any derivative transactions or a Rule 10b5-1 plan.
BP4 S.r.l., listed as a director of Milestone Scientific Inc. (MLSS), reported a sale of 10,000 shares of the issuer's common stock on 09/11/2025 at a price of $0.594 per share. After the transaction the filing indicates beneficial ownership of 9,256,972 shares, held indirectly. The Form 4 was signed by Dr. Pedro Palau, Liquidator and filed on 09/15/2025. The filing shows a single non-derivative disposition and does not disclose any derivative transactions or a Rule 10b5-1 plan.
Form 144 notice filed regarding proposed sale of 400,000 shares of Milestone Scientific, Inc. common stock, with an aggregate market value of $236,000, scheduled approximately for 09/10/2025 on the NYSE. The filing lists 78,559,147 shares outstanding for the class. The securities to be sold were originally acquired in a private placement on 05/14/2014 (2,000,000 shares) from Milestone Scientific, paid in cash. The form also reports a recent sale by BP4 Srl of 375,485 shares on 06/02/2025 for $301,082. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.